Loading
Latest filing published 16 Oct 2026 for Medicus Pharma Ltd..
No signal scores available.
Andrew Alasdair Smith appears in our data through filings on Medicus Pharma Ltd. shares, published by SEC (Form 4). Between 23 June 2025 and 12 October 2026, the trades on record add up to 6 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 16 October 2026, the filings show a transaction in Medicus Pharma Ltd. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations